Bioelectronics Corp (BIEL)

[GetSeriousOK]

That is some good DD. Thanks! I also tried contacting the PUMPP PI but haven't received an answer yet.

If the Allay study has an ETA of May 2019 for completion.... that suggests RecoveryRx is probably on a similar timeline... and it's not clear what the company has to do to re-submit the Back Pain study for Women Only. I *think* the FDA said the knee and foot clearances won't work as a predicate device because those studies were not gender specific.

Meanwhile, revenues decline the O/S increases. And the SEC settlement has hit a snag and it looks like they are going back to court, which will cost BIEL more $$$ to defend -- making the SEC case more expensive in the long run than an early settlement would have.